If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Baqsimi™ (glucagon) nasal powder
3mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
BAQSIMI™ (glucagon) nasal powder: Mechanism of Action
Glucagon increases blood glucose concentration by activating hepatic glucagon receptors, thereby stimulating glycogen breakdown and release of glucose from the liver.
Glucagon increases BG concentration by activating hepatic glucagon receptors, thereby stimulating
hepatic glycogen breakdown and
the release of glucose from the liver.1
Hepatic stores of glycogen are necessary for glucagon to produce an antihypoglycemic effect.1
Enclosed Prescribing Information
BAQSIMI™ (glucagon) nasal powder, for intranasal use, Lilly
1. Baqsimi [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.
Glossary
BG = blood glucose
Date of Last Review: July 24, 2019
Contact Lilly
Call Us
If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.
Available Mon - Fri, 8am - 7pm ET
